Expand BHC Menu
BHC MENU

BHC Latest Press Releases

-- July 7, 2026 --

Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026 PRNewswire 7:00 AM

-- July 6, 2026 --

Qubec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of schizophrenia PRNewswire 7:00 AM

-- July 1, 2026 --

Michael Goettler Resigns from Bausch Health's Board of Directors PRNewswire 4:15 PM

-- June 9, 2026 --

Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of (Pr)OKEDI (Risperidone for extended-release injectable suspension) for the treatment of schizophrenia PRNewswire 8:00 AM

-- May 28, 2026 --

Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage in China PRNewswire 4:15 PM

-- May 19, 2026 --

Bausch Health Announces 2026 Annual Meeting of Shareholder Results PRNewswire 4:15 PM

-- April 14, 2026 --

Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine, an Iconic French Skincare Product, Through Convenient Online Ordering PRNewswire 8:00 AM

-- March 31, 2026 --

Bausch Health to Announce First Quarter 2026 Results on April 29, 2026 PRNewswire 7:00 AM

-- March 26, 2026 --

Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program PRNewswire 8:00 AM

-- February 19, 2026 --

Bausch Health's OraPharma Celebrates 25 Years of ARESTIN (minocycline HCl) Microspheres PRNewswire 8:00 AM
Market Data Delayed 15 Minutes